Proteomics: Technologies and Global Markets

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $5,500	384 Pages	BCC Research	December, 2022	WA17550043

Best Price Guarantee
Price	from $5,500
Length	384 Pages
Publisher	BCC Research
Published Date	December, 2022
SKU	WA17550043

Proteomics: Technologies and Global Markets

Report Scope:

The study’s scope covers MS instruments, consumables, workflow products, planar arrays, bead arrays, and LOACs. It also covers the research, drug discovery and development, diagnostics, and applied end-user market segments. The main geographical markets—North America, Europe, Asia-Pacific, and Rest of the World (ROW)—are included.

The MS market is covered by instrument type, MS consumables, and product type and end-user markets. The biochip market is covered by biochip type and the end-user market for each type. The diagnostics market is covered in some detail, including by major platform (i.e., MS, biochips), by disease type and for cancer by indication. This report provides the current market sizes for these segments, as well as their forecasted growth to 2027.

Technology status and forces driving the market are discussed and analyzed. Factors that influence each market are also highlighted, including growth-driving forces, industry alliances and acquisitions, applications in diagnostics and drug discovery, customer needs, and competitive trends.

Key industry acquisitions and strategic alliances are given for the five-year period from 2021 through 2027.

This report examines the main patent trends within the industry and profiles proteomics companies.

Report Includes:

149 data tables and 97 additional tables

An up-to-date overview of the global markets for proteomics and related technologies

Analyses of the global market trends, with historic market revenue data from 2019 to 2021, estimates for 2022, and projections of compound annual growth rates (CAGRs) through 2027

Highlights of the upcoming market potential for the global proteomics industry, growth driving factors, and areas of focus to forecast this market into various segments and sub-segments

Estimation of the actual market size and market forecast for proteomics in value (USD millions) terms, and their corresponding market share analysis by platform technology, end-user application, and region

In-depth information (facts and figures) concerning major market dynamics (DROs), technology advancements, new products and applications in proteomics, and COVID-19 impact on the market for proteomics

Insight into recent industry structure for proteomics technologies, competitive aspects of each product segments, major growth strategies, and company value share analysis based on their segmental revenues

Updated information on key mergers and acquisition deals, agreements, partnerships, collaborations and product launches within the global proteomics industry

Profile descriptions of the leading proteomics manufacturers, including Agilent, Danaher Corp., GlaxoSmithKline PLC, PerkinElmer Inc., Qiagen GmbH, and Sanofi.

Companies Mentioned

ABCODIA LTD.
ACTIVX BIOSCIENCES INC.
ADVANCED PROTEOME THERAPEUTICS INC.
AGILENT TECHNOLOGIES INC.
APPLIED PROTEOMICS
ARRAYIT CORP.
ASTUTE MEDICAL INC.
AVACTA LIFE SCIENCES LTD.
AYOXXA BIOSYSTEMS GMBH
BECTON, DICKINSON AND CO.
BIO-RAD LABORATORIES INC.
BIO-TECHNE INC.
BIOCARTIS NV
BIODESIX INC.
BIOGNOSYS AG
BIOMERIEUX SA
BRUKER CORP.
CAMBRIDGE PROTEIN ARRAYS LTD.
CHARLES RIVER LABORATORIES INTERNATIONAL INC.
CRYSTALGENOMICS INC.
DANAHER CORP.
EPICYPHER INC.
EVOTEC AG
GENERAL ELECTRIC CO.
GL SCIENCES INC.
GLAXOSMITHKLINE PLC
ILLUMINA INC.
IMMUNOVIA AB
IMTAKT CORP.
INDI MOLECULAR
INTEGRATED DIAGNOSTICS HOLDING
LABCYTE INC.
LIMINAL BIOSCIENCES INC.
MERCK & CO. INC.
MERCK KGAA
MRM PROTEOMICS INC.
MYCARTIS
MYRIAD GENETICS INC.
NEWOMICS INC.
NIRMIDAS BIOTECH INC.
OLINK BIOSCIENCE
OPKO HEALTH INC.
PERKINELMER INC.
PERSONALIZED CANCER THERAPY INC.
PFIZER INC.
PHENOMENEX INC.
PRESSURE BIOSCIENCES INC.
PROTAGEN AG
PROTEA BIOSCIENCES INC.
PROTEOCYTE DIAGNOSTICS INC.
PROTEOGENIX
PROTEOME SCIENCES PLC
PROTEOMICS INTERNATIONAL PTY LTD.
PYC THERAPEUTICS. (FORMERLY PHYLOGICA LTD.)
QIAGEN N.V.
QUANSYS BIOSCIENCES
QUANTERIX INC.
QUEST DIAGNOSTICS INC.
REPLIGEN CORP.
ROCHE (F. HOFFMANN-LA ROCHE LTD.)
SAMDI TECH INC.
SANOFI
SERA PROGNOSTICS
SHIMADZU CORP.
SHISEIDO COMPANY LTD.
SHOWA DENKO KK
SINGULEX INC.
SISCAPA ASSAY TECHNOLOGIES INC.
SOMALOGIC INC.
SPOTON CLINICAL DIAGNOSTICS LTD.
SQI DIAGNOSTICS
STANDARD BIOTOOLS INC. (FORMERLY FLUIDIGM)
SYNAGEVA BIOPHARMA (ACQUIRED BY ALEXION PHARMACEUTICALS INC.)
T2 BIOSYSTEMS
THERMO FISHER SCIENTIFIC INC.
THORNE DIAGNOSTICS INC.
TOSOH CORP.
TRAJAN SCIENTIFIC AND MEDICAL
UNIVERSAL BIOSENSORS LTD.
VG LIFE SCIENCES INC.
WATERS CORP.
XENCOR INC.
YMC CO. LTD.

Chapter 1 Introduction: 1.1 Study Goals and Objectives; 1.2 Reasons for Doing the Study; 1.3 What's New in This Update?; 1.4 Scope of Report; 1.5 Intended Audience; 1.6 Methodology; 1.7 Information Sources; 1.8 Analyst's Credentials; 1.9 BCC Custom Research; 1.10 Related BCC Research Reports
Chapter 2 Summary and Highlights
Chapter 3 Overview: 3.1 Proteomic Technologies; 3.2 Scope of Report; 3.3 Proteomics Market; 3.4 Driving Forces for Proteomics Industry Growth; 3.4.1 Drivers; 3.4.2 Restraints; 3.4.3 Opportunities; 3.4.4 Challenge; 3.4.5 Proteomics Industry
Chapter 4 COVID 19 Impact on Proteomics Market: 4.1 Overview; 4.2 COVID-19 Crisis; 4.3 Impact on Market; 4.4 Current Outlook; 4.4.1 Implications on Cancer Diagnosis; 4.4.2 Key Reasons for Impact of COVID-19
Chapter 5 Proteomics Technologies: 5.1 Introduction; 5.2 MS-Based Proteomics Technologies; 5.2.1 Sample Preparation Assays; 5.2.2 Tagging/Affinity Methods; 5.2.3 Utility of Proteomics to Identify Biomarkers; 5.2.4 MS Instruments and Consumables; 5.3 Biochip-Based Proteomics Technologies; 5.3.1 Multiplex Proteomics Systems; 5.3.2 Proteogenomics; 5.3.3 Recent Advances in Proteomics Technologies
Chapter 6 Proteomics Applications in Drug Discovery and Development: 6.1 Target Discovery; 6.2 Lead Identification; 6.3 Lead Optimization; 6.4 Preclinical Studies
Chapter 7 Proteomics Scientific Initiatives
Chapter 8 Clinical Proteomics Applications: 8.1 Applications in Cancer; 8.1.1 Overview; 8.1.2 Bladder Cancer; 8.1.3 Breast Cancer; 8.1.4 Colorectal Cancer; 8.1.5 Gastric Cancer; 8.1.6 Kidney Cancer; 8.1.7 Lung Cancer; 8.1.8 Lymphomas; 8.1.9 Ovarian Cancer; 8.1.10 Pan-Cancer; 8.1.11 Prostate Cancer; 8.1.12 Thyroid Cancer; 8.1.13 Other Cancers; 8.2 Infectious Diseases; 8.3 Diabetes; 8.4 Neurological Disorders; 8.4.1 Alzheimer's Disease; 8.4.2 Schizophrenia; 8.5 Immune Diseases; 8.5.1 HLA Typing; 8.5.2 Autoimmune Disease; 8.6 Cardiovascular Disease; 8.7 Preeclampsia
Chapter 9 Proteomics Industry: 9.1 Industry Acquisitions; 9.2 Industry Strategic Alliances; 9.3 Mass Spectrometry Industry; 9.4 Chromatography Industry; 9.5 Proteomics-Based Drug Discovery and Development Industry; 9.6 Proteomics Biochip Industries; 9.6.1 Peptide Microarray Industry; 9.6.2 High-Density Protein Array Industry; 9.7 Antibody Microarray Industry; 9.8 China's Biochip Industry; 9.9 Lab-on-a-Chip Proteomics Industry; 9.10 Chemical Proteomics Industry; 9.11 Antibody Reagent Industry; 9.12 Multiplex Protein Diagnostics Industry; 9.13 Dried Blood Spotting Proteomics Industry; 9.14 Single Cell Proteomics Industry
Chapter 10 Proteomics Markets: 10.1 Driving Forces of Proteomics Industry Growth; 10.2 Global Proteomics Markets; 10.3 Market Summary; 10.4 Research Market; 10.5 Drug Discovery and Development Market; 10.6 Proteomics Diagnostic Market; 10.7 Mass Spectrometry-Based Proteomics Market; 10.8 Biochip-Based Proteomics Market
Chapter 11 Proteomics Market by Geographic Segmentation: 11.1 North America; 11.1.1 United States; 11.1.1 Canada; 11.2 Europe; 11.2.1 Impact of Brexit; 11.2.2 United Kingdom; 11.2.3 Germany; 11.2.4 France; 11.2.5 Italy; 11.2.6 Spain; 11.2.7 Rest of Europe; 11.3 Asia-Pacific; 11.3.1 China; 11.3.2 Japan; 11.3.3 India; 11.3.4 South Korea; 11.3.5 Australia; 11.3.6 Rest of Asia-Pacific; 11.4 Rest of the World (RoW)
Chapter 12 Proteomics Patents: 12.1 U.S. Proteomics Patents; 12.2 Protein Array Patents; 12.2.1 Lab-on-a-Chip Patents; 12.2.2 Mass Spectrometry Patents
Chapter 13 Competitive Landscape: 13.1 Genomics and Proteomic Tools/Technologies; 13.1.1 Sequencing Technologies; 13.1.2 PCR Technology; 13.1.3 Nucleic Acid Purification and Separation; 13.1.4 Nucleic Acid Separation Technologies
Chapter 14 Company Profiles: ABCODIA LTD.; ACTIVX BIOSCIENCES INC.; ADVANCED PROTEOME THERAPEUTICS INC.; AGILENT TECHNOLOGIES INC.; APPLIED PROTEOMICS; ARRAYIT CORP.; ASTUTE MEDICAL INC.; AVACTA LIFE SCIENCES LTD.; AYOXXA BIOSYSTEMS GMBH; BECTON, DICKINSON AND CO.; BIOCARTIS NV; BIODESIX INC.; BIOGNOSYS AG; BIOMERIEUX SA; BIO-RAD LABORATORIES INC.; BIO-TECHNE INC.; BRUKER CORP.; CAMBRIDGE PROTEIN ARRAYS LTD.; CHARLES RIVER LABORATORIES INTERNATIONAL INC.; CRYSTALGENOMICS INC.; DANAHER CORP.; EPICYPHER INC.; EVOTEC AG; GENERAL ELECTRIC CO.; GLAXOSMITHKLINE PLC; GL SCIENCES INC.; ILLUMINA INC.; IMMUNOVIA AB; IMTAKT CORP.; INTEGRATED DIAGNOSTICS HOLDING; INDI MOLECULAR; LABCYTE INC.; LIMINAL BIOSCIENCES INC.; MERCK & CO. INC.; MERCK KGAA; MRM PROTEOMICS INC.; MYCARTIS; MYRIAD GENETICS INC.; NEWOMICS INC.; NIRMIDAS BIOTECH INC.; OLINK BIOSCIENCE; OPKO HEALTH INC.; PERKINELMER INC.; PERSONALIZED CANCER THERAPY INC.; PFIZER INC.; PHENOMENEX INC.; PRESSURE BIOSCIENCES INC.; PROTAGEN AG; PROTEA BIOSCIENCES INC.; PROTEOCYTE DIAGNOSTICS INC.; PROTEOGENIX; PROTEOME SCIENCES PLC; PROTEOMICS INTERNATIONAL PTY LTD.; PYC THERAPEUTICS. (FORMERLY PHYLOGICA LTD.); QIAGEN N.V.; QUANSYS BIOSCIENCES; QUANTERIX INC.; QUEST DIAGNOSTICS INC.; REPLIGEN CORP.; ROCHE (F. HOFFMANN-LA ROCHE LTD.); SAMDI TECH INC.; SANOFI; SERA PROGNOSTICS; SHIMADZU CORP.; SHISEIDO COMPANY LTD.; SHOWA DENKO KK; SINGULEX INC.; SISCAPA ASSAY TECHNOLOGIES INC.; SOMALOGIC INC.; SPOTON CLINICAL DIAGNOSTICS LTD.; SQI DIAGNOSTICS; STANDARD BIOTOOLS INC. (FORMERLY FLUIDIGM); SYNAGEVA BIOPHARMA (ACQUIRED BY ALEXION PHARMACEUTICALS INC.); T2 BIOSYSTEMS; THERMO FISHER SCIENTIFIC INC.; THORNE DIAGNOSTICS INC.; TOSOH CORP.; TRAJAN SCIENTIFIC AND MEDICAL; UNIVERSAL BIOSENSORS LTD.; VG LIFE SCIENCES INC.; WATERS CORP.; XENCOR INC.; YMC CO. LTD.